RABBIO® AiRO delivers research-ready patients using integrated sources like EHR data and lab records to assess eligibility based on specific clinical, molecular, and genetic markers. This enables sponsors to arrive at research endpoints faster, secure product registration, and access markets faster. The solution reduces screen-out rates, speeds timelines, and lowers recruitment costs by 60%.